March 20, 2023
In re Bystolic Antitrust Litigation
Case Number:
23-410
Court:
Nature of Suit:
Companies
- AbbVie Inc.
- Albertsons Cos. Inc.
- Alkem Laboratories Ltd.
- Allergan PLC
- Amerigen Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Association for Accessible Medicines
- CVS Health Corp.
- Forest Laboratories Inc.
- Glenmark Pharmaceuticals Ltd.
- Hetero Drugs Ltd.
- J.M. Smith Corp.
- New Civil Liberties Alliance
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
- Torrent Pharmaceuticals Ltd.
- United Food & Commercial Workers International Union
- Washington Legal Foundation
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 13, 2024
2nd Circ. Affirms Dismissal Of Bystolic Antitrust Suit
The Second Circuit issued its first decision under the high court's Actavis "pay for delay" ruling on Monday, affirming the dismissal of a case alleging that an AbbVie predecessor delayed competition for its hypertension treatment Bystolic through deals with several generic makers.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login